The global pharmaceutical REMS market size was valued at USD 1.73 billion in 2024 and is expected to hit around USD 6.12 billion by 2034, growing at a compound annual growth rate (CAGR) of 13.64% over the forecast period from 2025 to 2034.
The pharmaceutical REMS market is expected to grow significantly due to increasing regulatory focus on drug safety, rising incidence of adverse drug reactions, complex specialty drug launches, and the need for risk mitigation strategies. There is also increasing awareness about safety concerning drugs which along with the movement towards personalized medicine further drives the demand for integrated robust REMS Solutions. Guidelines strengthen with time and aim to enhance monitoring and surveillance of drug safety, thus the overall market adapts to support safer medication use while improving patient outcomes in the advanced and evolving healthcare ecosystem.